A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RAVULIZUMAB IN COMPLEMENT-INHIBITOR-NAIVE ADULT PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
Principal Investigator(s)
Bhavaraju-Sanka, Ratna K.
Funded by
ALEXION PHARMACEUTICALS
Research Start Date
Status
Active